Hong Kong Building Stock News

Wharf Real Estate Investment Company (WREIC) announced that on 28 November 2025 it entered into a new three-year Master Hotel Services Agreement with Wharf, covering management, marketing, technical, procurement, training, financial and reservation services for its hotels and serviced apartments from 1 January 2026 to 31 December 2028. This refreshed framework for continuing connected transactions helps formalise long-term service arrangements within the wider Wharf group, providing clearer...

In the third quarter of 2025, NetEase reported higher sales and net income year over year, affirmed a US$0.114 per-share dividend, completed a US$2.00 billion buyback program, and saw its NetEase Cloud Music charts integrated into Chartmetric’s platform for global industry access. The Chartmetric integration gives international labels and artists direct visibility into youth-driven listening trends on NetEase Cloud Music, potentially increasing the platform’s influence in global music...

Bosideng International Holdings reported half-year results for the period ended September 30, 2025, with sales of CNY 8,927.64 million and net income of CNY 1,189.37 million, and its board recommended an interim dividend of HK$0.063 (approximately CNY 0.057) per share, payable in January 2026. While basic earnings per share were unchanged year on year at CNY 0.1035, the slight improvement in diluted earnings per share highlights incremental profitability gains even after factoring in...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Amidst a backdrop of global economic uncertainty and shifting monetary policies, Asian markets have shown resilience, with investor interest particularly piqued by the potential for undervalued opportunities. In this context, identifying stocks priced below their intrinsic worth can be a strategic move for investors looking to capitalize on market inefficiencies and long-term growth potential.

China Resources Pharmaceutical Group Limited recently proposed amending its articles of association to reflect updated Hong Kong rules on treasury shares and website-based shareholder communication, while its subsidiary CR Pharmaceutical Commercial received approval in China to register up to RMB3 billion in medium term notes for refinancing interest-bearing debt. Together, these changes highlight the group’s efforts to modernise its corporate framework and improve balance sheet flexibility...

Insiders were net buyers of Productive Technologies Company Limited's ( HKG:650 ) stock during the past year. That is...

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'll want to...

It is hard to get excited after looking at Vanov Holdings' (HKG:2260) recent performance, when its stock has declined...

With its stock down 30% over the past three months, it is easy to disregard Pop Mart International Group (HKG:9992...

Some Anton Oilfield Services Group ( HKG:3337 ) shareholders are probably rather concerned to see the share price fall...

Key Insights COSCO SHIPPING International (Hong Kong)'s estimated fair value is HK$6.94 based on 2 Stage Free Cash Flow...

China Digital Video Holdings Limited ( HKG:8280 ) shares have continued their recent momentum with a 31% gain in the...

Tianjin Binhai Teda Logistics (Group) Corporation Limited's ( HKG:8348 ) price-to-earnings (or "P/E") ratio of 20.8x...

Fengyinhe Holdings Limited ( HKG:8030 ) insiders who purchased shares in the last 12 months were richly rewarded last...

Gemdale Properties and Investment Corporation Limited ( HKG:535 ) shareholders should be happy to see the share price...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...

Unfortunately for some shareholders, the VPower Group International Holdings Limited ( HKG:1608 ) share price has dived...

As global markets adjust to evolving economic conditions, Asian stock indices have shown resilience, with particular interest in technology and AI sectors driving investor enthusiasm. Penny stocks, a term that may feel outdated yet remains relevant, often represent smaller or newer companies that can offer unique growth opportunities. By focusing on those with strong financial health and potential for long-term growth, investors might discover valuable prospects within this niche segment of...

China Galaxy Securities announced that it has successfully completed a non-public issuance of RMB 5 billion in corporate bonds on 19 November 2025, with two- and three-year maturities and coupon rates of 1.92% and 1.97%, respectively, aimed at refinancing maturing debts. This issuance saw substantial participation from leading financial institutions and related parties, highlighting confidence from key market players in the company’s credit profile. We'll explore how the strong institutional...

WuXi Biologics (Cayman) SEHK:2269 has just signed a strategic memorandum with the Qatar Free Zones Authority, opening the door for its first integrated CRDMO center in the Middle East. This move broadens the company’s reach and elevates its global footprint. See our latest analysis for WuXi Biologics (Cayman). Momentum has started to rebuild for WuXi Biologics (Cayman) as excitement over its Middle East expansion coincides with a notable year-to-date share price return of 86.6%. While shares...

Fosun International (SEHK:656) sits at the intersection of multiple sectors, including health care, insurance, and intelligent manufacturing. This combination makes it an interesting company to keep an eye on as the market shifts. See our latest analysis for Fosun International. Fosun International’s share price has shown signs of regained momentum lately, with a 1-day return of 2.87% and a year-to-date price return of 13.61%. While the 1-year total shareholder return sits at a solid 17.29%,...

CK Hutchison Holdings has been in discussions with financial advisers regarding a potential listing of its health and beauty retailer AS Watson Group, with reports suggesting the move could raise US$2.6 billion or more in Hong Kong and possibly involve a dual listing in the UK. An interesting insight is that AS Watson operates over 17,000 stores in 31 markets, making this potential IPO one of the most significant retail listings out of Asia in recent years. We'll examine how the possible AS...

Key Insights Duality Biotherapeutics' estimated fair value is HK$664 based on 2 Stage Free Cash Flow to Equity Duality...